The study was carried out between April 3 and June 19 to assess
potential bottlenecks in manufacturing the vaccine and the global
capacity available to produce them, CEPI said in a statement on
Wednesday.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/globally-cos-can-produce-2-4-b-covid-vaccine-doses-by-21-end/articleshow/77400541.cms
No comments:
Post a Comment